PL413830A1 - Kompleks laktoferyny z jonami manganu, sposób jego otrzymywania, zastosowanie kompleksu oraz kompozycja farmaceutyczna zawierająca kompleks laktoferyny i jonów manganu - Google Patents
Kompleks laktoferyny z jonami manganu, sposób jego otrzymywania, zastosowanie kompleksu oraz kompozycja farmaceutyczna zawierająca kompleks laktoferyny i jonów manganuInfo
- Publication number
- PL413830A1 PL413830A1 PL413830A PL41383015A PL413830A1 PL 413830 A1 PL413830 A1 PL 413830A1 PL 413830 A PL413830 A PL 413830A PL 41383015 A PL41383015 A PL 41383015A PL 413830 A1 PL413830 A1 PL 413830A1
- Authority
- PL
- Poland
- Prior art keywords
- complex
- lactoferrin
- manganese ions
- pharmaceutical composition
- composition containing
- Prior art date
Links
- 102000010445 Lactoferrin Human genes 0.000 title abstract 4
- 108010063045 Lactoferrin Proteins 0.000 title abstract 4
- CSSYQJWUGATIHM-IKGCZBKSSA-N l-phenylalanyl-l-lysyl-l-cysteinyl-l-arginyl-l-arginyl-l-tryptophyl-l-glutaminyl-l-tryptophyl-l-arginyl-l-methionyl-l-lysyl-l-lysyl-l-leucylglycyl-l-alanyl-l-prolyl-l-seryl-l-isoleucyl-l-threonyl-l-cysteinyl-l-valyl-l-arginyl-l-arginyl-l-alanyl-l-phenylal Chemical compound C([C@H](N)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CS)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CS)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(O)=O)C1=CC=CC=C1 CSSYQJWUGATIHM-IKGCZBKSSA-N 0.000 title abstract 4
- 229940078795 lactoferrin Drugs 0.000 title abstract 4
- 235000021242 lactoferrin Nutrition 0.000 title abstract 4
- 229910001437 manganese ion Inorganic materials 0.000 title abstract 4
- 238000000034 method Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 235000015872 dietary supplement Nutrition 0.000 abstract 1
- 230000002496 gastric effect Effects 0.000 abstract 1
- 244000005706 microflora Species 0.000 abstract 1
- 239000000825 pharmaceutical preparation Substances 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/79—Transferrins, e.g. lactoferrins, ovotransferrins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
Przedmiotem zgłoszenia jest kompleks laktoferyny z jonami manganu, sposób jego otrzymywania i zastosowanie, zwłaszcza do wytwarzania suplementu diety i/lub preparatu farmaceutycznego do leczenia i/lub profilaktyki dolegliwości związanych z mikroflorą układu pokarmowego, jak również kompozycja farmaceutyczna zawierająca kompleks laktoferyny i jonów manganu.
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL413830A PL238483B1 (pl) | 2015-09-04 | 2015-09-04 | Kompleks laktoferyny z jonami manganu, sposób jego otrzymywania, zastosowanie kompleksu oraz kompozycja farmaceutyczna zawierająca kompleks laktoferyny i jonów manganu |
| PCT/IB2016/055218 WO2017037641A1 (en) | 2015-09-04 | 2016-09-01 | A complex of lactoferrin with manganese ions, a method of manufacturing use and a pharmaceutical composition comprising complex of lactoferrin with manganese ions |
| EP16778879.3A EP3344653B1 (en) | 2015-09-04 | 2016-09-01 | A complex of lactoferrin with manganese ions, a method of manufacturing use and a pharmaceutical composition comprising complex of lactoferrin with manganese ions |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PL413830A PL238483B1 (pl) | 2015-09-04 | 2015-09-04 | Kompleks laktoferyny z jonami manganu, sposób jego otrzymywania, zastosowanie kompleksu oraz kompozycja farmaceutyczna zawierająca kompleks laktoferyny i jonów manganu |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| PL413830A1 true PL413830A1 (pl) | 2017-03-13 |
| PL238483B1 PL238483B1 (pl) | 2021-08-30 |
Family
ID=57121453
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL413830A PL238483B1 (pl) | 2015-09-04 | 2015-09-04 | Kompleks laktoferyny z jonami manganu, sposób jego otrzymywania, zastosowanie kompleksu oraz kompozycja farmaceutyczna zawierająca kompleks laktoferyny i jonów manganu |
Country Status (3)
| Country | Link |
|---|---|
| EP (1) | EP3344653B1 (pl) |
| PL (1) | PL238483B1 (pl) |
| WO (1) | WO2017037641A1 (pl) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114129713B (zh) * | 2021-11-23 | 2024-05-24 | 南方科技大学 | 乳铁蛋白活性肽或编码该活性肽的核苷酸序列在制备抗炎和/或抗氧化产品中的应用 |
| CN118754970A (zh) * | 2024-09-05 | 2024-10-11 | 杭州纽龙生物科技有限公司 | 一种载锌乳铁蛋白制备方法、载锌乳铁蛋白和应用 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0389795T3 (da) * | 1989-02-25 | 1993-08-02 | Morinaga Milk Industry Co Ltd | Bioaktive midler |
-
2015
- 2015-09-04 PL PL413830A patent/PL238483B1/pl unknown
-
2016
- 2016-09-01 EP EP16778879.3A patent/EP3344653B1/en active Active
- 2016-09-01 WO PCT/IB2016/055218 patent/WO2017037641A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| PL238483B1 (pl) | 2021-08-30 |
| WO2017037641A1 (en) | 2017-03-09 |
| EP3344653B1 (en) | 2020-11-18 |
| EP3344653A1 (en) | 2018-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2018002546A (es) | Composiciones que comprenden un compuesto de urolitina. | |
| PH12015501648A1 (en) | 2-aminopyrimidine derivatives for the treatment of viral infections | |
| WO2016134335A3 (en) | Pvrig polypeptides and methods of treatment | |
| MX2018002543A (es) | Composiciones que comprenden compuestos de urolitina. | |
| MX370792B (es) | Composiciones para usarse en el tratamiento de cáncer. | |
| EA201790273A1 (ru) | Флагеллиновые композиции и их применение | |
| PH12018501279A1 (en) | Compositions comprising 15-hepe and methods of using the same | |
| MX2019005855A (es) | Formulaciones que se pueden pulverizar. | |
| IL261982A (en) | A prophylactic and therapeutic preparation based on peroxaphthalate, especially a pharmaceutical preparation | |
| MX2019002057A (es) | Formas solidas de mesilato de cenicriviroc y procesos para elaborar formas sólidas de mesilato de cenicriviroc. | |
| MY180844A (en) | Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions | |
| PH12017500348B1 (en) | Tetrahydroquinoline derivatives as bromodomain inhibitors | |
| IN2014CH00840A (pl) | ||
| HK1254231A1 (zh) | 米托-和厚朴酚化合物及其合成方法和用途 | |
| GB2527233A (en) | Composition comprising hydrocortisone | |
| EP3297636A4 (en) | Pharmaceutical composition of carboplatin based co-crystals and use thereof | |
| MX370436B (es) | Composicion farmaceutica para usarse en el tratamiento o la prevencion de deficiencias de vitaminas y minerales en pacientes que han sido sometidos a cirugia de derivacion gastrica. | |
| MX2015001648A (es) | Composiciones que comprenden derivados de espicamicina y metodos de uso de los mismos. | |
| PL413830A1 (pl) | Kompleks laktoferyny z jonami manganu, sposób jego otrzymywania, zastosowanie kompleksu oraz kompozycja farmaceutyczna zawierająca kompleks laktoferyny i jonów manganu | |
| MA40642A (fr) | Nouveaux dérivés peptidiques et leurs utilisations | |
| PH12019500180A1 (en) | Compositions for the treatment of pulmonary fibrosis | |
| PL420267A1 (pl) | Ekstrakt z grzyba poliporoidalnego, kompozycja zawierająca ten ekstrakt oraz jego zastosowanie | |
| GEAP202014778A (en) | Combination of trazodone and gabapentin for the treatmen | |
| EA201990041A1 (ru) | Композиции, содержащие тимолол, и их применение при лечении розацеа при местном применении | |
| MY182809A (en) | Compositions for the treatment of kidney and/or liver disease |